medigraphic.com
ISSN 0188-2198 (Print)

2001, Number 1

<< Back Next >>

Rev Mex Cardiol 2001; 12 (1)

Special circumstances

Alcocer BL, Zamora GC, Fernández LM, Oceguera MJ

Language: Spanish
References: 44
Page: 43-53
PDF size: 219.54 Kb.


Text Extraction

No abstract


REFERENCES

  1. National Heart Lung and Blood Institute: Report of the second task force, on blood pressure control in children. Pediatrics 1987; 79: 1-25.

  2. Delgado J, Acoltzin C. Cifras de tensión arterial en niños y adolescentes en Colima. Tesis profesional 1994, Universidad de Colima, Méx.

  3. Perloff D et al. Human blood pressure determination by sphygmomanometry. Circulation 1993; 88: 2460-2465.

  4. Ingelfinger JR. Pediatric hypertension. Philadelphia, U.S.A., WB Saunders. 1982.

  5. Adelman RD. Pediatric hypertension. Ped Clin North Am 1978: 25-99.

  6. Burt VL, Whelton P, Roccella EJ el al. Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313.

  7. Rodríguez J, Chávez R, Marmolejo R, Reynoso MT. Epidemiología de la hipertensión arterial en México. Aspectos históricos. Med Int (Méx) 1996; 13: 283-288.

  8. Sepúlveda J, Rull, Tapia R. Encuesta Nacional de Enfermedades Crónicas. Dirección General de Epidemiología e Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, (INCMNSZ) Secretaría de Salud, México D.F. 1993.

  9. Rodríguez-Saldaña J, Sosa-Espinosa P, García-Martínez MA, Marmolejo-Henderson R, Reynoso-Marenco MA, Amaro-Lima N. Enfermedad hipertensiva en ancianos mexicanos: prevalencia, clasificación y grado de control. Salud Púb Méx (enviado a publicación).

  10. WHO Expert Committee. Hypertension control. Ginebra: World Health Organization, 1996.

  11. Escobedo J, Escamilla JA, Santos C. Arch Inst Cardiol (Méx) 1994; 64: 189-195.

  12. Dirección General de Epidemiología (Méx). Boletín de Vigilancia Epidemiológica 1997, 1998, 1999.

  13. Instituto Nacional de Estadística, Geografía e Informática (INEGI). Información estadística del Sector Salud y Seguridad Social. Aguascalientes Ags. (Méx), 1998.

  14. Kaplan NM. Primary hypertension: natural history, special populations and evaluation. In: Kaplan NM. Clinical Hypertension, 7a ed. Baltimore MD: Willianis & Wilkins; 1998: 115-116.

  15. Kannel WB, Wolf PA, McGee DL, Dawber TR, McNamara P, Castelli WP. Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham Study. JAMA 1981; 245: 1225-1229.

  16. Kannel WB, D’Agostino RB, Silbershatz H. Blood pressure and cardiovascular morbidity and mortality rates in the elderly. Am Heart J 1997; 134: 758-763.

  17. Nichols WW, O’Rourke MF. Aging. In: McDondald’s Blood Flow in Arteries: theoretical, experimental and clinical principles, 4a ed. Londres UK: Arnold; 1998: 347-376.

  18. Domanski MJ, Davis BR, Pfeffer MA, Kastantin M, Mitchell GF. Isolated systolic hypertension. Prognostic information provided by pulse pressure. Hypertension 1999; 34: 375-380.

  19. O’Rourke M, Frolilich ED. Pulse pressure. Is this a clinically useful risk factor? Hypertension 1999; 34: 372-374.

  20. Lyon RT, Runyon-Hass A, Davis HR, Glagov S, Zarins CK. Protection from atherosclerotic lesion formation by reduction of artery wall motion. J Vasc Surg 1987; 5: 59-67.

  21. Staessen JA, Fagard R, Thijs L et al. Morbidity and mortality in the placebo controlled European Trial on Isolated Systolic Hypertension in the Elderly. Lancet 1997; 360: 757-764.

  22. Sagie A, Larson MG, Levy D. The natural history of borderline isolated systolic hypertension. N Engl J Med 1993; 329: 1912-1917.

  23. Lloyd-Jones DM, Evans JC, Larson MG, O’Donnell CJ, Levy D. Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Hypertension 1999; 34: 381-385.

  24. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of high Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.

  25. The fourth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of high Blood Pressure. Arch Intern Med 1988; 148: 1023-1038.

  26. Black HR. The paradigm has shifted, to systolic blood pressure. Hypertension 1999; 34: 386-387.

  27. Connolly JO, Higgins RM, Walters HL et al. Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease. Q J Med 1994; 87: 413-421.

  28. Perloff D, Grim C, Flack J. Human blood pressure determination by sphygmomanometry. Circulation 1993; 88: 2460-2470.

  29. Reeves RA. Does this patient have hypertension? How to measure blood pressure. JAMA 1995; 273: 1211-1217.

  30. Anzal M, Palmer AJ, Starr J, Bulpitt CJ. The prevalence of pseudohypertension in the elderly. J Hum Hypertens 1996; 10: 409-411.

  31. Applegate WB. The elderly patient with hypertension. In: Izzo JL, Black HR (eds). Hypertension Primer, 2a ed. Dallas Tx; American Heart Association; 1999: 238.

  32. Fotherby MD, Potter JF. Reproducibility of ambulatory and clinic blood pressure measurements in elderly hypertensive subjects. J Hypertens 1993; 11: 573-579.

  33. Streeten DHP. Management of orthostatic hypotension, hypertension and tachycardia. In: Izzo JL, Black HR (eds). Hypertension Primer, 2a ed. Dallas Tx; American Heart Association; 1999: 390-392.

  34. Sagie A, Larson MG, Levy D. The natural history of borderline isolated systolic hypertension. N Engl J Med 1993; 329: 1912-1917.

  35. Mulrow CD, Cornell JA, Herrera CR et al. Hypertension in the elderly. JAMA 1994; 272: 1932-1938.

  36. Hamet P, Gong L. Antihypertensive therapy debate: contribution from the Shangai trial of nifedipine in the elderly (STONE). J Hypertens 1996; 14(supl): S9-S14.

  37. Staessen JA, Fagard R, Thijs L et al. Morbidity and mortality in the placebo controlled European trial on isolated systolic hypertension in the elderly. Lancet 1997;

  38. Black HR. Management of hypertension in older persons. In: Izzo JL, Black HR (eds). Hypertension Primer, 2a ed. Dallas Tx; American Heart Association; 1999: 430-432.

  39. López Llera MM. La toxemia del embarazo. (2a. ed.) Méx., D. F., Méx., Limusa. 1985.

  40. O’Brien WF. Pronóstico de la preeclampsia. Clin Obstet Gynecol 1991; 2: 341-359.

  41. Sibai BM. Hipertension crónica durante el embarazo. Clin Perinatol 1991; 4: 813-826.

  42. López JJ et al. Calcium supplementation reduces the risk of pregnancy induced hypertension in Andes population. Br J Obstet Gynaecol 1989; 96: 648-655.

  43. Sibai BM. Tratamiento de la preeclampsia. Clin Perinatol 1991; 4: 773-788.

  44. Hanssens M, Keirse MJNC et al. Fetal and neonatal effects of treatment with angiotensin-converting-enzyme inhibitor in pregnancy. Am J Obstet Gynecol 1991; 163: 1689-1712.




2020     |     www.medigraphic.com